Retinal detachment, vitreous hemorrhage, and foveal hypoplasia associated with 3q27.1q27.2 microdeletion: a case report.

Autor: Tahbaz M; Department of Medicine, Morsani College of Medicine, University of South Florida, Tampa, Florida., Ebrahimiadib N; Department of Ophthalmology, University of Florida, Gainesville, Florida., Iyer SSR; Vitreoretinal Associates, Gainesville, Florida., Steele C; Invitae Corporation, Tampa, Florida., Roohipourmoallai R; Department of Ophthalmology, Morsani Hospital, University of South Florida, Florida. Electronic address: ramak2@usf.edu.

Publikováno v: Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus [J AAPOS] 2024 Aug; Vol. 28 (4), pp. 103960. Date of Electronic Publication: 2024 Jun 26.

Improving Cognitive Function Through High-Intensity Interval Training in Breast Cancer Patients Undergoing Chemotherapy: Protocol for a Randomized Controlled Trial.

Autor: Wilson R; Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Harvard Medical School, Boston, MA, United States., Kang DW; Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Harvard Medical School, Boston, MA, United States., Tahbaz M; Department of Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL, United States., Norris M; Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States., Uno H; Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Harvard Medical School, Boston, MA, United States., Ligibel J; Harvard Medical School, Boston, MA, United States.; Division of Breast Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States., Guenette J; Division of Neuroradiology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Boston, MA, United States., Christopher C; Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States., Dieli-Conwright C; Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Harvard Medical School, Boston, MA, United States.

Publikováno v: JMIR research protocols [JMIR Res Protoc] 2023 Apr 07; Vol. 12, pp. e39740. Date of Electronic Publication: 2023 Apr 07.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Targeting Adiposity and Inflammation With Movement to Improve Prognosis in Breast Cancer Survivors (The AIM Trial): Rationale, Design, and Methods.

Autor: Kang DW; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Department of Medicine, Harvard Medical School, Boston, MA, United States., Wilson RL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Department of Medicine, Harvard Medical School, Boston, MA, United States., Gonzalo-Encabo P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Department of Medicine, Harvard Medical School, Boston, MA, United States., Norris MK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States., Hans M; Division of Breast Surgery, Brigham and Women's Hospital, Boston, MA, United States., Tahbaz M; Department of Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL, United States., Dawson J; Department of Physical Therapy, California State University, Long Beach, Long Beach, CA, United States., Nguyen D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States., Normann AJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Department of Health Sciences, Boston University, Boston, MA, United States., Yunker AG; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, United States., Sami N; Department of Medicine, University of Southern California, Los Angeles, CA, United States., Uno H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Department of Medicine, Harvard Medical School, Boston, MA, United States., Ligibel JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Department of Medicine, Harvard Medical School, Boston, MA, United States., Mittelman SD; Children's Discovery and Innovations Institute, University of California, Los Angeles, Los Angeles, CA, United States., Dieli-Conwright CM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Department of Medicine, Harvard Medical School, Boston, MA, United States.

Publikováno v: Frontiers in oncology [Front Oncol] 2022 Jun 20; Vol. 12, pp. 896995. Date of Electronic Publication: 2022 Jun 20 (Print Publication: 2022).

Immune Protection of Stem Cell-Derived Islet Cell Therapy for Treating Diabetes.

Autor: Tahbaz M; Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA, United States., Yoshihara E; Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA, United States.; David Geffen School of Medicine at University of California, Los Angeles, CA, United States.

Publikováno v: Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2021 Aug 10; Vol. 12, pp. 716625. Date of Electronic Publication: 2021 Aug 10 (Print Publication: 2021).